Last reviewed · How we verify
6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)
A multicenter, randomized, parallel-group, double-blind, fixed dose, 6-week trial of the efficacy and safety of asenapine compared with placebo in participants with an acute exacerbation of schizophrenia.
Details
| Lead sponsor | Organon and Co |
|---|---|
| Phase | PHASE3 |
| Status | COMPLETED |
| Enrolment | 532 |
| Start date | Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Apr 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Schizophrenia
Interventions
- Asenapine 5 mg
- Asenapine 10 mg
- Placebo